Two Sigma Securities’s Ligand Pharmaceuticals LGND Stock Holding History

Two Sigma Securities’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,980	Closed	-$208K	–	1510
2020 Q2	$208K	Buy	+2,980	New	+$189K	﹤0.01%	1128
2018 Q2	–	Sell	-5,090	Closed	-$524K	–	2850
2018 Q1	$524K	Buy	+5,090	New	+$503K	﹤0.01%	1636
2017 Q3	–	Sell	-3,498	Closed	-$265K	–	1085
2017 Q2	$265K	Buy	+3,498	New	+$245K	0.05%	408
2016 Q3	–	Sell	-3,243	Closed	-$241K	–	734
2016 Q2	$241K	Buy	+3,243	New	+$241K	0.13%	213

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Two Sigma Securities's LGND Position: Q3 2020 in Review

Two Sigma Securities sold out of Ligand Pharmaceuticals (LGND) in Q3 2020, closing a stake of 2,980 shares — an estimated $208K sold.

Two Sigma Securities first reported a position in LGND in Q2 2016 and held it in 4 quarters. The position peaked at $524K in Q1 2018. 252 funds tracked by Wall St. Rank hold LGND as of Q3 2020.

Two Sigma Securities reported no remaining Ligand Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Two Sigma Securities sold 2,980 Ligand Pharmaceuticals shares in Q3 2020, an estimated $208K.
Two Sigma Securities first reported a position in Ligand Pharmaceuticals in Q2 2016 and held it in 4 quarters.
Two Sigma Securities's Ligand Pharmaceuticals position peaked at $524K in Q1 2018.
252 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2020.

Based on Two Sigma Securities's 13F filing for Q3 2020, filed 16 Nov 2020.